Stay updated on KarXT for Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis Clinical Trial page
- Check7 days agoChange DetectedThe page adds new recruitment sites and investigators (including CHU de Reims and Fondazione Policlinico A Gemelli - Rome; Jean Luc Novella at Site 2501 and Camillo Marra at Site 2303), updates informed consent language and caregiver/contraception requirements, and expands the study plan with time-to-relapse endpoints (up to Week 38) and related safety and outcome measures.SummaryDifference0.6%

- Check14 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small behind-the-scenes update with no changes to the displayed study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This update generally reflects minor corrections or updates; specific content changes are not listed.SummaryDifference0.0%

- Check36 days agoChange DetectedNew trial sites were added across multiple countries (e.g., South Korea, Italy, India, France, Czechia, Serbia, Spain, and more) with Not yet recruiting status, expanding the study's geographic reach. The total number of locations was updated to reflect these additions, and a few previously listed sites and location references were removed.SummaryDifference2%

- Check50 days agoChange DetectedThe page revision is updated from v3.6.2 to v3.6.3, indicating a new version of the page. This is a metadata revision rather than a content change.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, reflecting a newer version of the page content.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.